Log in
RegisterDonepezil SR 23 mg Tablets BE study [Study Performance]
Dear all,
We are planning to conduct a bioequivalence study on Donepezil SR 23 mg tablets in comparision with 10 mg IR tablets for US regulatory. We would like to know whether this study is feasible to be conducted in healthy population or in patients?
If the study need to be conducted in patients, what is the severity of the diseased condition (mild/moderate/severe) to be selected?
With Regards,
Madhav
We are planning to conduct a bioequivalence study on Donepezil SR 23 mg tablets in comparision with 10 mg IR tablets for US regulatory. We would like to know whether this study is feasible to be conducted in healthy population or in patients?
If the study need to be conducted in patients, what is the severity of the diseased condition (mild/moderate/severe) to be selected?
With Regards,
Madhav
Complete thread:
- Donepezil SR 23 mg Tablets BE studymadhavaraob 2010-07-07 07:27 [Study Performance]
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- Donepezil SR 23 mg Tablets BE study drgunasakaran1 2010-07-17 07:23
- Donepezil SR 23 mg Tablets BE study madhavaraob 2010-07-22 09:06
- Donepezil SR 23 mg Tablets BE study Pavidus 2010-07-22 10:09
- Donepezil SR 23 mg Tablets BE study chaitanyag 2010-07-23 05:18
- Donepezil SR 23 mg Tablets BE study Pavidus 2010-07-22 10:09
- Donepezil SR 23 mg Tablets BE study chaitanyag 2010-07-26 14:34
- CROs Helmut 2010-07-26 15:01
- Donepezil SR 23 mg Tablets BE study Dr. Solanki 2010-08-07 10:28
- Donepezil SR 23 mg Tablets BE study Dr. Solanki 2010-08-12 11:30
- Donepezil SR 23 mg Tablets BE study madhavaraob 2010-07-22 09:06
- Donepezil SR 23 mg Tablets BE study drgunasakaran1 2010-07-17 07:23
Ing. Helmut Schütz